New Released Reagents

New Reagent

The search engine found new reagents in the following categories.




SARS-CoV-2

Showing 1 to 20 of 22 Results12
BEI NumberDescriptionLevelReleased DateDescending Order
NR-56789 SARS-Related Coronavirus 2 Isolate hCoV-19/USA/MD-HP28972/2022 (Lineage BA.2.12.1) BEI Level 3 March 2024
NR-56465 Spike Glycoprotein Receptor Binding Domain (RBD) from SARS-Related Coronavirus 2, B.1.1.529 (Omicron) with C-Terminal Histidine Tag, Recombinant from HEK293 Cells SARS-Related Coronavirus 2 BEI Level 1 March 2024
NR-55294 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Clone 2TP1B3 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 March 2024
NR-58700 Peptide Array, SARS-Related Coronavirus 2 Non-Structural Protein 12 (NSP12) SARS-Related Coronavirus 2 BEI Level 1 March 2024
NR-59686 SARS-Related Coronavirus 2 Isolate hCoV-19/USA/CA-AK001/2023 (Lineage FL.1.5.1) BEI Level 3 February 2024
NR-59615 Genomic RNA from SARS-Related Coronavirus 2, Isolate hCoV-19/USA/MD-HP47946/2023 (Lineage EG.5.1; Omicron Variant) SARS-Related Coronavirus 2 BEI Level 2 February 2024
NR-58702 Peptide Array, SARS-Related Coronavirus 2 Non-Structural Protein 13 (NSP13) SARS-Related Coronavirus 2 BEI Level 1 February 2024
NR-58701 Peptide Array, SARS-Related Coronavirus 2 Non-Structural Protein 7 (NSP7) SARS-Related Coronavirus 2 BEI Level 1 February 2024
NR-59471 A549-ACE2plusC3 Cell Line BEI Level 2 January 2024
NR-59693 SARS-Related Coronavirus 2 Isolate hCoV-19/USA/New York/PV96109/2023 (Lineage JN.1; Omicron Variant) BEI Level 3 December 2023
NR-59638 SARS-Related Coronavirus 2 SARS-Related Coronavirus 2, Isolate hCoV-19/USA/MI-UM-10052670540/2023 (Lineage BA.2.86) in VTA Cells BEI Level 3 December 2023
NR-59500 SARS-Related Coronavirus 2 Isolate hCoV-19/USA/MD-HP47866/2023 (Lineage GJ.2; Deposited as XBB.2.3.3) BEI Level 3 December 2023
NR-58917 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 65.3.1 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 November 2023
NR-58919 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 92.1.1 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 November 2023
NR-58914 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 58.2.2 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 November 2023
NR-58912 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 34.2.2 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 November 2023
NR-58913 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 57.1.2 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 November 2023
NR-58916 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 62.1.1 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 November 2023
NR-58918 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 82.6.2 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 November 2023
NR-59501 SARS-Related Coronavirus 2 Isolate hCoV-19/USA/MD-HP47865/2023 (Lineage XBB.2.3; Omicron Variant) BEI Level 3 November 2023
Showing 1 to 20 of 22 Results12